Skip to main content
. 2017 Aug 8;113(3):550–557. doi: 10.1016/j.bpj.2017.06.042

Table 1.

Overview of Peptides Used in This Study

Ensemble No. of Sequences Sequence Length, N Reference
Poly-valine 9 20,30,40,80,100,200,300,400,450 N/A
IDP-like 9 20,30,40,80,100,200,300,400,450 DisProt
IDP 12 40,61,92,95,104,110,112,140,189,198,234,237 (43)

See Supporting Material for additional details.